Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone.
about
Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acidIn vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.Endogenous production of lipoic acid is essential for mouse developmentTargeting cellular energy production in neurological disorders.The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitroReducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.Alpha-lipoic acid supplementation and diabetesAlpha-lipoic Acid and diabetic neuropathy.Pharmacological therapy in Parkinson's disease: focus on neuroprotection.Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure.Dietary strategies to recover from exercise-induced muscle damage.Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage.Dihydrolipoic acid reduces cytochrome b561 proteins.Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes.Neuropharmacological effects of lipoic acid and ubiquinone on the mRNA level of interleukin-1β and acetylcholinesterase activity in rat hippocampus after seizures.Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells.Alleviation of bone markers in rats induced nano-zinc oxide by qurecetin and α-lipolic acid.Anodic Oxidation of α‐Lipoic Acid at a Glassy Carbon Electrode and Its Determination in Dietary Supplements
P2860
Q28361014-C29D8753-879C-437E-BFB0-2B3CD851581FQ33966185-2D44CE94-471D-4CFC-B422-017C921F3A35Q34042851-C69DF3BC-55E8-4C2E-BDAA-921CD30CE0FFQ34266266-8DF0E977-0CEF-4E67-A3EE-537B28239751Q34627401-01F2D5C6-B657-417D-ADF6-4F118E240A74Q36212135-EF819670-462E-4BC3-8535-AC31FA185A15Q37329377-407987D4-9B5C-4182-8699-0CB49B343D49Q37665315-08507D8E-D0B0-40C5-807C-276E4748705FQ37741285-3BC7D22A-A52E-4F97-ACF3-1D09759FB74CQ37780643-FDF02DBE-BE67-493E-81AB-3369B9118412Q38158175-41D411B2-787B-450C-AB06-DF3A024B5DCAQ38854377-F65CEE81-F399-4ABC-8702-1893DB5769C4Q43966259-8A2B5EE9-BFB5-4DD9-A1E9-3EDF7CA5302BQ44808735-DA4D570B-2FF3-49BC-AC20-D0D7A4F654D6Q48150078-9B2D053E-B62B-42B5-B92B-EE22CA7BDAB7Q50896214-4B3F8FA9-154C-4894-8B7F-7D6697136DD8Q51360505-3C8D9D75-6955-443E-A791-3BC25E7C6784Q58302908-045063B0-E980-4A32-86DE-1787F7459D1E
P2860
Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@ast
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@en
type
label
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@ast
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@en
prefLabel
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@ast
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@en
P2093
P356
P1476
Dihydrolipoic acid maintains u ...... n reduction of ubisemiquinone.
@en
P2093
P304
P356
10.1006/ABBI.1998.1064
P407
P577
1999-03-01T00:00:00Z